1017604-09-9 Usage
Description
Methyl 5-(4-morpholinyl)-2-pyrazinecarboxylate is a chemical compound characterized by the molecular formula C11H14N4O3. It is an ester derivative of 2-pyrazinecarboxylic acid, featuring a morpholine ring within its structure. This versatile compound is widely recognized for its potential in the pharmaceutical industry and organic chemistry, making it a valuable asset for scientists and researchers.
Uses
Used in Pharmaceutical Industry:
Methyl 5-(4-morpholinyl)-2-pyrazinecarboxylate is utilized as a building block for the synthesis of various compounds, including potential drug candidates. Its unique structure and reactivity contribute to the development of new molecules with promising biological activities, enhancing the discovery of novel therapeutic agents.
Used in Research and Development:
In the realm of research and development, this compound serves as a key component in the creation of new molecules with potential applications in medicine and biology. Its ability to form carbon-carbon and carbon-nitrogen bonds makes it instrumental in the synthesis of complex organic molecules, broadening the scope of chemical research.
Used in Organic Chemistry:
Methyl 5-(4-morpholinyl)-2-pyrazinecarboxylate is employed in the field of organic chemistry for the synthesis of new carbon-carbon and carbon-nitrogen bonds. Its versatile reactivity allows for the exploration of innovative synthetic pathways and the generation of novel chemical entities, further expanding the horizons of organic synthesis.
Check Digit Verification of cas no
The CAS Registry Mumber 1017604-09-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,1,7,6,0 and 4 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1017604-09:
(9*1)+(8*0)+(7*1)+(6*7)+(5*6)+(4*0)+(3*4)+(2*0)+(1*9)=109
109 % 10 = 9
So 1017604-09-9 is a valid CAS Registry Number.
1017604-09-9Relevant articles and documents
COLLAGEN 1 TRANSLATION INHIBITORS AND METHODS OF USE THEREOF
-
Paragraph 00299, (2021/12/31)
The present invention relates to novel collagen translation inhibitors 1, a composition, their preparation methods, and their uses for the treatment of fibrosis in particular, fibrosis of the lung, liver, kidney, cardiac and dermal fibrosis, IPF, wound he
COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS
-
Page/Page column 150, (2019/04/26)
The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.
IMIDAZO[4,5-C]PYRIDINE AND PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS SSAO INHIBITORS
-
Page/Page column 34-35, (2014/09/29)
The compounds of formula (I) are inhibitors of semicarbazide- sensitive amine oxidase (SSAO) activity useful in the treatment of inflammation, an inflammatory disease, an immune or an autoimmune disorder, or inhibition of tumour growth.